List of securities and quantities scheduled for demat auction under settlement number 812 dated February 5, 2026.
Impact
Medium
Severity
Medium
Justification
Routine demat auction notice affecting 142 securities with varying quantities. Medium importance as it impacts specific shareholders who failed to deliver securities in time, requiring them to participate in auction or face buy-in consequences.
BSE demat auction settlement listing 139 scrips with quantities to be auctioned for settlement number 812 dated February 5, 2026.
Impact
Medium
Severity
Medium
Justification
Routine demat auction settlement affecting 139 scrips with varying quantities. This is a standard market operation to address delivery failures, impacting specific brokers and clients who failed to deliver securities.
BSE demat auction settlement listing securities and quantities for settlement number 812, involving multiple scrips across various sectors including power, finance, infrastructure, and manufacturing companies.
Impact
Medium
Severity
Medium
Justification
Settlement auction affects trading members and participants with short delivery obligations across 140+ scrips. Medium impact as it's a routine settlement mechanism but involves significant number of securities and quantities.
BSE announces demat auction settlement 812 dated February 5, 2026, listing 138 securities with their respective quantities subject to auction.
Impact
Medium
Severity
Medium
Justification
Routine demat auction settlement affecting 138 securities with specified quantities. Important for brokers and participants with pending obligations in these scrips but not a market-wide policy change.
Listing of 9,987,258 equity shares of Vineet Laboratories Limited issued on rights basis at Rs. 10/- each with premium of Rs. 20/-, effective February 5, 2026.
Impact
Low
Severity
Low
Justification
Routine listing of rights issue shares for a single company with no broader market implications
9,987,258 equity shares of Vineet Laboratories Limited issued on rights basis at Rs. 30 per share listed and permitted to trade with effect from February 5, 2026.
Impact
Low
Severity
Low
Justification
Routine listing of rights issue shares for a single company with no broader market implications
BSE revises price bands for 30 securities effective January 19, 2026, with bands ranging from 2% to 20% based on surveillance measures.
Impact
Medium
Severity
Medium
Justification
Affects 30 securities with revised price bands under surveillance measures, limiting daily price movement but impacting only specific stocks rather than broad market.
BSE announces revised price bands for 30 scrips ranging from 2% to 20%, effective January 19, 2026, impacting trading limits across multiple securities.
Impact
Medium
Severity
Medium
Justification
Affects trading parameters for 30 securities with varied price bands, impacting daily trading limits and volatility controls for these stocks.